More information
Quincy Bioscience aims to reduce the burden of neurological disorders for those afflicted and for their loved ones through the discovery, development and commercialization of novel medicines to treat the diseases which share a common etiology – an imbalance of calcium ions. Quincy Bioscience is the only company to look into the calcium balancing neuroprotective properties of apoaequorin, a naturally derived calcium-binding protein from a species of jellyfish, breaking new ground in the fight against age-related disease
